Pergoquin, 1 mg tablets for horses
Pergoquin, 1 mg tablets for horses
Authorised
- Pergolide mesilate
Product identification
Medicine name:
Pergoquin, 1 mg tablets for horses
Active substance:
- Pergolide mesilate
Target species:
-
Horse
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Pergolide mesilate1.31/milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN04BC02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Cardboard box of 200 tablets containing Aluminium-OPA, Aluminium, PVC blisters containing 10 tablets.
- Cardboard box of 160 tablets containing Aluminium-OPA, Aluminium, PVC blisters containing 10 tablets.
- Cardboard box of 150 tablets containing Aluminium-OPA, Aluminium, PVC blisters containing 10 tablets.
- Cardboard box of 100 tablets containing Aluminium-OPA, Aluminium, PVC blisters containing 10 tablets.
- Cardboard box of 50 tablets containing Aluminium-OPA, Aluminium, PVC blisters containing 10 tablets.
- Cardboard box of 60 tablets containing Aluminium-OPA, Aluminium, PVC blisters containing 10 tablets.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetviva Richter GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V547626
Date of authorisation status change:
Reference member state:
-
Netherlands
Procedure number:
- NL/V/0295/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Labelling
This document does not exist in this language (English). You can find it in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 9/09/2025